Clinical trial

BK Virus in Salivary Gland Disease: Treating the Potential Etiologic Agent

NCT02068846

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-04-01

PhasePHASE3

Study timeline

Study start (actual)2014-04-01Date precision: month

Registry last updated2019-07-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIVunresolved

Salivary Gland Diseaseunresolved

Benign Lymphoepithelial Lesionunresolved

Interventions

CiprofloxacinDRUG · verified · RxNorm: ciprofloxacin

PlaceboDRUG

Sponsors & collaborators

University of North Carolina, Chapel Hilllead sponsor

National Institute of Dental and Craniofacial Research (NIDCR)collaborator

Mapped research locations

Chapel HillNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02068846 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.